Detalhe da pesquisa
1.
The Effect of Concomitant Proton Pump Inhibitor and Cabozantinib on the Outcomes of Patients with Metastatic Renal Cell Carcinoma.
Oncologist
; 26(5): 389-396, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33554383
2.
Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.
Oral Oncol
; 148: 106623, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38006691
3.
Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial.
Nat Commun
; 15(1): 1633, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38395948
4.
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.
Science
; 380(6649): eabo2296, 2023 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37289890
5.
Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma.
J Cachexia Sarcopenia Muscle
; 13(5): 2405-2416, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35903892
6.
Activity of Systemic Treatments After Cabozantinib Failure in Advanced Metastatic Renal Cell Carcinoma.
Clin Genitourin Cancer
; 20(1): 80-87, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688544
7.
Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.
Clin Genitourin Cancer
; 20(5): 488-494, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977881
8.
Cancer Induces a Stress Ileopathy Depending on ß-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis.
Cancer Discov
; 12(4): 1128-1151, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34930787
9.
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.
Cancer Discov
; 12(4): 958-983, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35179201
10.
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.
Cancer Discov
; 12(10): 2280-2307, 2022 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35929803
11.
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade.
JCI Insight
; 6(2)2021 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33320838
12.
New pathways in immune stimulation: targeting OX40.
ESMO Open
; 5(1)2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32392177
13.
Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses.
Oncoimmunology
; 9(1): 1789284, 2020 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923151
14.
Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors.
Oncoimmunology
; 9(1): 1794423, 2020 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32934888
15.
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.
Eur Urol
; 78(2): 195-206, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32376136